Commentary on the treatment effects of selegiline transdermal system on symptoms of major depressive disorder: a meta-analysis of short-term, placebo-controlled, efficacy trials.
Carlat
Daniel J
DJ
Tufts University School of Medicine, Boston, MA, USA.
D000928:Antidepressive Agents / Q000008:administration & dosage*; D003865:Major Depressive Disorder / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000008:administration & dosage*; D012642:Selegiline / Q000008:administration & dosage*
D000928:Antidepressive Agents; D008996:Monoamine Oxidase Inhibitors; D012642:Selegiline